Peter Attia· MD
the study was called to reduce it which was an acronym as they all are for for something reduce it was the name of the study the product was called vicita like vascular EPA the ASC EPA a company that makes the drugs called Ameren and the way the study was done they gave four grams a day of this EPA it's EPA ethyl ester so it's a very purified EPA that has a FL ester which is the typical way that they used they concentrate omega-3 years nowadays four grams a day versus the four grams of a mineral oil placebo which has had some controversy as to whether that's a real placebo or not roughly 8,000 patients who all were on statin drugs to control their cholesterol levels and they all still had triglycerides between two and five hundred roughly 150 to 500 so triglycerides were still elevated even though they were on a statin cholesterol LDL cholesterol was roughly in the 70s so there was low healthy levels of LDL they also had to have either a history of heart disease or some other risk factors and like having diabetes for example was another way you could get in so if you met that criteria that kind of patient you were given either four grams of placebo or four grams of VAS SEPA